What Researchers Did
The European Committee for Hyperbaric Medicine (ECHM) convened a workshop to discuss controversial indications for hyperbaric oxygen therapy (HBOT) and propose statements based on expert reports and audience votes.
What They Found
The workshop addressed the use of HBOT in conditions like aseptic bone necrosis, global brain ischaemia, and autism, where routine recommendations are not yet established. Specialists presented current pathophysiological, experimental, and clinical evidence, followed by reports from facilities with clinical experience. Discussions led to proposed statements, which were voted on by the audience and presented to the ECHM Executive Board, including a proposal for HBOT use in femoral head necrosis.
What This Means for Canadian Patients
Canadian patients considering hyperbaric oxygen therapy for conditions not routinely recommended should be aware of the ongoing international debate regarding its efficacy. This study underscores the importance of seeking treatments based on strong scientific evidence rather than anecdotal reports.
Canadian Relevance
This study has no direct Canadian connection as it focuses on the recommendations and activities of the European Committee for Hyperbaric Medicine.
Study Limitations
A limitation of this workshop report is that it summarizes expert discussions and proposed statements rather than presenting new primary clinical research or definitive, universally accepted treatment guidelines.